Aemetis Inc (AMTX) - Net Assets
Based on the latest financial reports, Aemetis Inc (AMTX) has net assets worth $-321.14 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($270.33 Million) and total liabilities ($591.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AMTX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-321.14 Million |
| % of Total Assets | -118.8% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 365.31 |
Aemetis Inc - Net Assets Trend (2004–2025)
This chart illustrates how Aemetis Inc's net assets have evolved over time, based on quarterly financial data. See Aemetis Inc (AMTX) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Aemetis Inc (2004–2025)
The table below shows the annual net assets of Aemetis Inc from 2004 to 2025. For live valuation and market cap data, see Aemetis Inc (AMTX) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-306.83 Million | -16.26% |
| 2024-12-31 | $-263.93 Million | -21.64% |
| 2023-12-31 | $-216.98 Million | -7.49% |
| 2022-12-31 | $-201.85 Million | -67.88% |
| 2021-12-31 | $-120.24 Million | +34.92% |
| 2020-12-31 | $-184.74 Million | -19.67% |
| 2019-12-31 | $-154.37 Million | -46.21% |
| 2018-12-31 | $-105.58 Million | -34.68% |
| 2017-12-31 | $-78.39 Million | -57.37% |
| 2016-12-31 | $-49.81 Million | -41.14% |
| 2015-12-31 | $-35.29 Million | -1087.55% |
| 2014-12-31 | $-2.97 Million | +76.72% |
| 2013-12-31 | $-12.77 Million | +42.50% |
| 2012-12-31 | $-22.20 Million | 0.00% |
| 2011-12-31 | $-22.20 Million | -134.96% |
| 2010-12-31 | $-9.45 Million | -156.11% |
| 2009-12-31 | $-3.69 Million | -173.89% |
| 2008-12-31 | $4.99 Million | -78.78% |
| 2007-12-31 | $23.53 Million | +29366.36% |
| 2006-12-31 | $-80.39K | -937.97% |
| 2005-12-31 | $9.59K | -50.25% |
| 2004-12-31 | $19.28K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aemetis Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 63962871600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $66.00K | % |
| Other Comprehensive Income | $-7.36 Million | % |
| Other Components | $340.40 Million | % |
| Total Equity | $-306.83 Million | 100.00% |
Aemetis Inc Competitors by Market Cap
The table below lists competitors of Aemetis Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Superkrane Mitra Utama Tbk PT
JK:SKRN
|
$135.14 Million |
|
Owlet Inc
NYSE:OWLT
|
$135.15 Million |
|
China Automotive Systems Inc
NASDAQ:CAAS
|
$135.16 Million |
|
Wam Alternative Assets Ltd
AU:WMA
|
$135.20 Million |
|
GrafTech International Ltd
NYSE:EAF
|
$135.04 Million |
|
GAMCO Natural Resources Gold and Income Closed Fund
NYSE:GNT
|
$134.99 Million |
|
ProCap Financial, Inc.
NASDAQ:BRR
|
$134.95 Million |
|
ISC Fresh Water Investment SOCIMI SA
MC:YISC
|
$134.95 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aemetis Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -263,928,000 to -306,831,000, a change of -42,903,000.
- Net loss of 77,001,000 reduced equity.
- New share issuances of 28,075,000 increased equity.
- Other comprehensive income decreased equity by 990,000.
- Other factors increased equity by 7,013,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-77.00 Million | -25.1% |
| Share Issuances | $28.07 Million | +9.15% |
| Other Comprehensive Income | $-990.00K | -0.32% |
| Other Changes | $7.01 Million | +2.29% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Aemetis Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | $0.05 | $1.92 | x |
| 2005-12-31 | $0.03 | $1.92 | x |
| 2006-12-31 | $-0.24 | $1.92 | x |
| 2007-12-31 | $3.13 | $1.92 | x |
| 2008-12-31 | $0.59 | $1.92 | x |
| 2009-12-31 | $-0.39 | $1.92 | x |
| 2010-12-31 | $-1.08 | $1.92 | x |
| 2011-12-31 | $-2.14 | $1.92 | x |
| 2012-12-31 | $-2.14 | $1.92 | x |
| 2013-12-31 | $-0.67 | $1.92 | x |
| 2014-12-31 | $-0.14 | $1.92 | x |
| 2015-12-31 | $-1.78 | $1.92 | x |
| 2016-12-31 | $-2.52 | $1.92 | x |
| 2017-12-31 | $-3.95 | $1.92 | x |
| 2018-12-31 | $-5.21 | $1.92 | x |
| 2019-12-31 | $-7.54 | $1.92 | x |
| 2020-12-31 | $-8.79 | $1.92 | x |
| 2021-12-31 | $-3.92 | $1.92 | x |
| 2022-12-31 | $-5.84 | $1.92 | x |
| 2023-12-31 | $-5.70 | $1.92 | x |
| 2024-12-31 | $-5.75 | $1.92 | x |
| 2025-12-31 | $-4.66 | $1.92 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aemetis Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -37.02%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-22.51%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -55.58% | 0.00% | 0.00x | 1.03x | $-12.65K |
| 2005 | -100.99% | 0.00% | 0.00x | 1.13x | $-10.65K |
| 2006 | 0.00% | -14.83% | 64.85x | 0.00x | $-94.66K |
| 2007 | -21.44% | 0.00% | 0.00x | 1.43x | $-7.40 Million |
| 2008 | -317.11% | -1941.51% | 0.03x | 4.71x | $-16.34 Million |
| 2009 | 0.00% | -119.60% | 0.47x | 0.00x | $-10.64 Million |
| 2010 | 0.00% | -103.60% | 0.38x | 0.00x | $-7.48 Million |
| 2011 | 0.00% | -12.90% | 5.21x | 0.00x | $-16.08 Million |
| 2012 | 0.00% | -2.27% | 6.94x | 0.00x | $-2.06 Million |
| 2013 | 0.00% | -13.77% | 1.83x | 0.00x | $-23.16 Million |
| 2014 | 0.00% | 3.43% | 2.33x | 0.00x | $7.43 Million |
| 2015 | 0.00% | -18.51% | 1.76x | 0.00x | $-23.61 Million |
| 2016 | 0.00% | -10.92% | 1.84x | 0.00x | $-10.65 Million |
| 2017 | 0.00% | -20.18% | 1.59x | 0.00x | $-22.46 Million |
| 2018 | 0.00% | -19.25% | 1.87x | 0.00x | $-22.46 Million |
| 2019 | 0.00% | -17.68% | 2.02x | 0.00x | $-20.28 Million |
| 2020 | 0.00% | -22.14% | 1.32x | 0.00x | $-18.18 Million |
| 2021 | 0.00% | -22.24% | 1.32x | 0.00x | $-35.12 Million |
| 2022 | 0.00% | -42.01% | 1.24x | 0.00x | $-87.57 Million |
| 2023 | 0.00% | -24.86% | 0.77x | 0.00x | $-24.72 Million |
| 2024 | 0.00% | -32.71% | 1.03x | 0.00x | $-61.14 Million |
| 2025 | 0.00% | -37.02% | 0.80x | 0.00x | $-46.32 Million |
Industry Comparison
This section compares Aemetis Inc's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $918,438,145
- Average return on equity (ROE) among peers: 9.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aemetis Inc (AMTX) | $-321.14 Million | -55.58% | N/A | $135.10 Million |
| Albemarle Corp (ALB) | $1.33 Billion | 17.24% | 1.12x | $18.76 Billion |
| Alto Ingredients Inc (ALTO) | $3.57 Million | -41.59% | 0.13x | $212.84 Million |
| Air Products and Chemicals Inc (APD) | $2.10 Billion | 12.92% | 1.14x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $2.17 Billion | 5.38% | 2.09x | $2.95 Billion |
| Avient Corp (AVNT) | $1.05 Billion | 55.91% | 2.11x | $3.38 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.50 Billion | 12.80% | 3.71x | $6.23 Billion |
| Balchem Corporation (BCPC) | $60.93 Million | 17.98% | 0.23x | $5.17 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $1.52 Million | 1.74% | 0.09x | $5.91 Million |
| Bon Natural Life Ltd (BON) | $44.35 Million | 0.90% | 0.39x | $7.61 Million |
About Aemetis Inc
Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. The company operates through California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel segments. It engages in the operation, acquisition, development, and commercialization of low and negative carbon intensity products and technologies that replace fossil fuel products. The company also produces … Read more